Artificial carriers: A strategy for constructing antigenic/immunogenic conjugates

Current Topics in Medicinal Chemistry

Volumn 6, Issue 16, 2006, Pages 1715-1735

  Sakarellos Daitsiotis, Maria ^a   Krikorian, Dimitrios ^a   Panou Pomonis, Eugenia ^a   Sakarellos, Constantinos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Artificial conjugates; Dendrimers; Immunoassays; Multimeric core matrices; Sequential Oligopeptide Carriers; Site specific antibodies; Templates with built in folding devices

Indexed keywords

ANTIBODY CONJUGATE; BOVINE SERUM ALBUMIN; DENDRIMER; DRUG CARRIER; EPITOPE; GLYCOPROTEIN; HERPES SIMPLEX VACCINE; KEYHOLE LIMPET HEMOCYANIN; OLIGOPEPTIDE; OVALBUMIN; PEPTIDE DERIVATIVE; POLYPEPTIDE; TETANUS TOXOID; VACCINE;

ANTIBODY SPECIFICITY; ANTIGENICITY; BIOSYNTHESIS; CHEMICAL STRUCTURE; HERPES SIMPLEX; IMMUNOASSAY; IMMUNOGENICITY; LEISHMANIA; MYASTHENIA GRAVIS; NONHUMAN; RELIABILITY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; STRUCTURE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; DRUG CARRIERS; HUMANS; IMMUNOGENETICS; OLIGONUCLEOTIDES; PEPTIDE FRAGMENTS; VACCINES, SYNTHETIC;

EID: 33748329541     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606778194190     Document Type: Review

References (149)

1. Sela, M. Antigenicity: Some molecular aspects. Science 1969, 166, 1365-1374.
2. Arnon, R.; Maron, E.; Sela, M.; Anfinsen, C.B. Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proc. Natl. Acad. Sci. USA 1971, 68, 1450-1455.
3. Sela, M. Immunological studies with synthetic polypeptides. Adv. Immunol. 1966, 5, 29-129.
4. Muller, S. Use of synthetic peptides for the analysis of B-cell epitopes in autoantigens. In NATO ASI Series, Vol. H 80. Autoimmunity: Experimental Aspects. Zomali, M.; Berlin, Heidelberg: Springer-Verlag, 1994, pp 75-89.
5. Elkon, K.B. Use of synthetic peptides in the detection and quantification of autoantibodies. Mol. Biol. Rep. 1992, 16, 207-212.
6. Sakarellos-Daitsiotis, M.; Panou-Pomonis, E. Peptides as probes for studying autoimmune diseases. In Research Trends, Current Topics in Peptide & Protein Research. Richard, R.; T.C. 17/250(3), Poojapura Trivandrum-695012, India, 2004, 6, pp 81-91.
7. Lerner, R. A. Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature 1982, 299, 592-596.
8. Lerner, R. A. Antibodies of predetermined specificity in biology and medicine. Adv. Immunol. 1984, 36, 1-44.
9. Arnon, R.; Van Regenmortel, M. H. V. Structural basis of antigenic specificity and design of new vaccines. FASEB J. 1999, 6, 3265-3274.
10. Walter, G. Production and use of antibodies against synthetic peptides. J. Immunol. Methods, 1986, 88, 149-161.
11. Harlow, E.; Lane, D. Antibodies. A laboratory manual. Cold Spring Harbor Laboratory 1985.
12. Briand, J. P.; Muller, S.; Van Regenmortel, M. H. V. Synthetic peptides as antigens: pitfalls of conjugation methods. J. Immunol. Methods 1985, 78, 56-69.
13. Schutze, M. P.; LeClerc, C.; Jolivet, F.; Audibert, F.; Chedid, L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 1985, 135, 2319-2322.
14. Veprek, P.; Jezek, J. Peptide and glycopeptide dendrimers. Part I. J. Peptide Sci. 1999, 5, 5-23.
15. Veprek, P.; Jezek, J. Peptide and glycopeptide dendrimers. Part II. J. Peptide Sci. 1999, 5, 203-220.
16. Neurath, A. R.; Kent, S. B. H. Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 1982, 79, 7871-7875.
17. Jacob, C. O.; Amon, R.; Sela, M. Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. Mol. Immunol. 1985, 22, 1333-1339.
18. Cohen, G. H.; Dietzschold, B.; Ponce de Leon, M.; Long, D.; Golub, E.; Varrichio, A.; Pereira, L.; Eisenberg, R. J. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol. 1984, 49, 102-108.
19. Walter, G.; Scheidtmann, K. H.; Carbone, A.; Laudano, A. P.; Doolittle, R. F. Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc. Natl. Acad. Sci. USA 1980, 77, 5197-5200.
20. Pfaff, E.; Mussgay, M.; Böhm, H. O. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1982, 1, 869-874.
21. Dent, A. H. Conjugation methods. In the immunoassay handbook. Wild, D.; Nature publishing group, 2nd edition, 2001, pp 211-228.
22. Audibert, F., Jolivet, M.; Chedid, L.; Arnon, R.; Sela, M. Successful immunization with a totally synthetic diphtheria vaccine. Proc. Natl. Acad. Sci. USA 1982, 79, 5042-5046.
23. Kaumaya, P. T.; Berndt, K. D.; Heidorn, D. B.; Trewhella, J.; Kezdy, F. J.; Goldberg, E. Synthesis and biophysical characterization of engineered topographic immunogenic determinants with alpha alpha topology. Biochemistry 1990, 29, 13-23.
24. Kobs-Conrad, S.; Lee, H.; DiGeorge, A. M.; Kaumaya, P. T. Engineered topographic determinants with alpha beta, beta alpha beta, and beta alpha beta alpha topologies show high affinity binding to native protein antigen (lactate dehydrogenase-C4). J. Biol. Chem. 1993, 268, 25285-25295.
25. Sundaram, R.; DaKappagari, N. K.; Kaumaya, P. T. Synthetic peptides as cancer vaccines. Biopolymers 2002, 66, 200-216.
26. Kaumaya, P. T.; Kobs-Conrad, S.; Seo, Y. H.; Lee, H. VanBuskirk, A. M.; Feng, N., Sheridan, J.; Stevens, V. Peptide vaccines incorporating a "promiscuous" T-cell epitope by pass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. J. Mol. Recognit. 1993, 6, 81-94.
27. Tam, J. P. High-density multiple antigen-peptide system for preparation of antipeptide antibodies. Methods Enzymol. 1989, 168, 7-15.
28. Posnett, D. N.; Tam, J. P. Multiple antigenic peptide method for producing antipeptide site-specific antibodies. Methods Enzymol. 1989, 178, 739-746.
29. Tam J. P.; Lu, Y. A. Coupling difficulty associated with interchain clustering and phase transition in solid phase peptide synthesis. J. Am. Chem. Soc. 1995, 117, 12058-12063.
30. Tam, J. P. Macropeptide structures. Synthesis of peptide dendrimers and protein mimetics. In Houben-Weyl, Methods of Organic Chemistry. Synthesis of Peptides and Peptidomimetics. Goodman, M.; Felix, A.; Moroder, L.; Toniolo, C. (eds). Thieme: Stuttgard, 2003, E22d: 129-168.
31. Merrifield, R. B. Solid-phase peptide synthesis. In Peptides: Synthesis, Structures and Applications. Gutte, B. (ed). Academic Press, San Diego, 1995, pp 93-169.
32. Stewart, J. M.; Young, J. D. Principles of Peptide Synthesis, Second ed. Pierce Chemical Co, Rockford IL, 1984.
33. Bodansky, M. Principles of Peptide Synthesis, Second ed. Springer: Berlin, 1993.
34. Basak, A.; Boudreault, A.; Chen, A.; Chretien, M.; Seidah, N. G.; Lazure, C. Application of the multiple antigenic peptides (MAP) strategy to the production of prohormone convertases antibodies: synthesis characterization and use of 8-branched immunogenic peptides. J. Peptide Sci. 1995, 1, 385-395.
35. Keah, H. H.; Kacorius, E.; Hearn, M. T. W. Direct synthesis and characterization of multidedritic peptides for use as immunogens. J. Peptide Res. 1998, 51, 2-8.
36. Benz, H. The role of solid-phase fragment condensation in peptide synthesis. Synthesis 1994, 337-358.
37. Kaiser, E. T.; Nihara, H.; Laforet, G. A.; Kelly, J. W.; Walters, L.; Findeis, M.A.; Sasaki, T. Peptide and Protein synthesis by segment synthesis-condensation. Science 1989, 243, 187-192.
38. Tam J. P; Xu, J.; Eom, K. D. Methods and strategies of peptide ligation. Biopolymers (Pep. Sci.) 2001, 60, 194-205.
39. Sadler, K.; Tam, J. P. Peptide dendrimers: applications and synthesis, Rev. Mol. Biotechnol. 2002, 90, 195-229.
40. Shao, J.; Tam, J. P.; Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages. J. Am. Chem. Soc. 1995, 117, 3893-3899.
41. Tam, J. P.; Spetzler, J. C. Chemoselective approaches to the preparation of peptide dendrimers and branched artificial proteins using unprotected peptides as building blocks. Biomed. Peptide Protein Nucl. Acids 1995, 1, 123-132.
42. Tam, J. P.; Clavijo, P.; Lu, Y-A.; Nussenzweig, V.; Nussenzweig, R.; Zavala, F. Incorporation of T and B epitopes of the circumsporzoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 1990, 171, 299-306.
43. Chai, S. K.; Clavijo, P.; Tam, J. P.; Zavala, F. Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. J. Immunol. 1992, 149, 2385-2390.
44. Levi, M.; Ruden, M.; Birx, D.; Loomis, L.; Redfield, R.; Lovgren, K,; Akerblom, L.; Sandstrom, E.; Wahren, B. Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp 160 of HIV-1. J. Acquired Immune Defic. Syndr. 1993, 6, 855-864.
45. Nardelli, B.; Defoort, J. P.; Huang, W.; Tam, J.P. Design of a complete synthetic peptide - based AIDS vaccine with a built-in adjuvant. AIDS Res. Hum. Retroviruses 1992, 8, 1405-1407.
46. Wang, L. X.; Ni, J.; Singh, S. Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling. synthesis of multivalent HIV-1 gp41 peptides. Bioorg. Med. Chem. 2003, 11, 159-166.
47. Briand, J. P.; Barin, C.; Van Regenmortel, M. H. V.; Müller, S. J. Application and limitations of multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. J. Immunol. Methods 1992, 156, 255-265.
48. Waldron, E. E.; Murray, P.; Kolar, Z.; Young, L.; Reynolds, G.; Baumforth, K.; Toomey, S.; Astley, S.; Perera, S. A.; Nelson, P. N. Reactivity and isotype profiling of monoclonal antibodies using multiple antigenic peptides. Hybrid. Hybridomics 2002, 21, 393-398.
49. Mahale, S. D.; Pereira, J.; Natraj, U.; Iyer, K. S. Comparison of antibodies raised against the peptide 10-24 of chicken riboflavin carrier protein (cRCP) by classical and multiple antigen peptide (MAP) approaches. J. Immunol. Methods 1996, 190, 215-219.
50. Sela, M. In Molecules, cells and parasites in immunology; Larralde, C.; Wills, K.; Ortiz-Ortiz, L.; Sela, M.; Eds.; Academic Press: New York, 1980; pp 215-218.
51. Hudecz, F.; Price, M. R. Monoclonal antibody binding to peptide epitopes conjugated to synthetic blanched polypeptide carriers. Influence of the carrier upon antibody recognition. J. Immunol. Methods 1992, 147, 201-210.
52. Hudecz, F.; Votavova, H.; Goal, D.; Sponar, J.; Kajtar, J.; Blaha, K.; Szekerke, M. In Polymeric Materials in Medication; Gebelein, Ch. G.; Carraher, Ch. E.; Eds.; Plenum Press: New York, 1985; pp 265-289.
53. Mezö, G.; Hudecz, F.; Kajitar, J., Szokan, Gy.; Szekerke, M. The influence of the side-chain sequence on the structure-activity correlations of immunodulatory branched polypeptides. Synthesis and conformational analysis of new model polypeptides. Biopolymers 1989, 28, 1801-1826.
54. Mezö, G.; Kajtar, J.; Hudecz, F.; Szekerke, M. Carrier design: conformational studies of amino acid (X) and oligopeptide (X-DL-Alam) substituted poly (L-lysine). Biopolymers 1993, 33, 873-885.
55. Hudecz, F. Design of synthetic branched-chain polypeptides as carriers for bioactive molecules. Anticancer Drugs 1995, 6, 171-193.
56. Hudecz, F.; Kutassi-Kovacs, S.; Mezö, G.; Szekerke, M. Biodegradability of synthetic branched polypeptide with poly(L-lysine) backbone. Biol. Chem. Hoppe Seyler 1989, 370, 1019-1026.
57. Clegg, J. A.; Hudecz, F.; Pimm, M.; Baldwin, R. W. Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone. Bioconjug. Chem. 1990, 1, 425-430.
58. Pimm, M. V.; Clegg, J. A., Hudecz, F.; Baldwin, R. W. Int. J. Pharcaceutis 1992, 79, 77-80.
59. Hudecz, F.; Kajtar, J.; Szekerke, M. Influence of side-chain-terminating moieties on the conformation of branched polypeptides and their conjugates with 4-ethoxymethylene-2-phenyl-5(4H)-oxazolone. Biophys. Chem. 1988, 31, 53-61.
60. Rajnavolgyi, E.; Zanyi, A.; Hudecz, F.; Kurucz, I.; Kiss, K.; Zaszlo, G.; Szekerke, M., Gergely, J. Structural characteristics influencing the carrier function of synthetic branched polypeptides based on poly[Lys-(DL-Ala)3)]backbone. Mol. Immunol. 1989, 26, 949-958.
61. Hudecz, F.; Hilbert, A.; Mezö, G.; Mucsi, I.; Kajtar, J.; Bösze, Sz.; Kurucz, I.; Rajnavolgyi, E. Epitope mapping of the 273-284 region of HSV glycoprotein D by synthetic branched polypeptide carrier conjugates. Pept. Res. 1993, 6, 263-271.
62. Hudecz, F. Alteration of immunogenicity and antibody recognition of B-cell epitopes by synthetic branched chain polypeptide carriers with poly[L-lysine] backbone. Biomed. Pept. Proteins Nucleic Acids 1995, 1, 213-220.
63. Mezö, G.; Kajtar, J.; Nagy, I.; Majer, Zs.; Szekerke, M.; Hudecz, F. Carrier design: Synthesis and conformational studies of poly[L-lysine] based branched polypeptides with hydroxyl groups. Biopolymers 1997, 42, 719-730.
64. Hudecz, F.; Gaal, D.; Kurucz, I.; Zanyi, S.; Kovacs, A. L.; Mezö, G.; Rajnavolgyi, E.; Szekerke, M. Carrier design: Cytotoxicity and immunogenicity of synthetic branched polypeptides with poly[L-lysine] backbone. J. Controlled Release 1992, 19, 231-243.
65. Rajnavolgyi, E.; Hudecz, F.; Mezö, G.; Szekerke, M.; Gergely, J. Isotype distribution and fine specificity of the antibody response of inbred mouse strains to four compounds belonging to a new group of synthetic branched polypeptides. Mol. Immunol. 1986, 23, 27-37.
66. Hudecz, F.; Pimm, M. V.; Rajnavolgyi, E.; Mezö, G.; Fabra, A.; Gaal, D.; Kovacs, A. L.; Horvath, A.; Szekerke, M. Carrier design: new generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicity. Bioconjug. Chem. 1999, 10, 781-790.
67. Hudecz, F. Manipulation of epitope function by modification of peptide structure: a minireview. Biologicals 2001, 29, 197-207.
68. Mezö, G.; Oliveira, E.; Krikorian, D.; Feijlbrief, M.; Jakab, A.; Tsikaris, V.; Sakarellos, C.; Welling-Wester, S.; Andreu, D.; Hudecz, F.; Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjug. Chem. 2003, 14, 1260-1269.
69. Creighton, T. E. Toward a better understanding of protein folding pathways. Proc. Natl. Acad. Sci. USA 1988, 85, 5082-5086.
70. Creighton, T. E. Structures and molecular properties. 2nd ed., Freeman: New York 1993.
71. Baldwin, R. L. How does protein folding get started? Trends Biochem. Sci. 1989, 14, 291-294.
72. Kemp, D. S. Peptidomimetics and the template approach to nucleation of beta-sheets and alpha-helices in peptides. Trends Biotechnol. 1990, 8, 249-255.
73. Mutter, M.; Vuilleumier, S. A chemical approach to protein design - template - assembled synthetic proteins (TASP). Aggew. Chem. Int. Ed. Engl. 1989, 28, 535-554.
74. Dumy, P.; Eggleston, I. M.; Esposito, G.; Nicula, S.; Mutter, M. Solution structure of regioselectively addressable functionalized templates: an NMR and restrained molecular dynamics investigation. Biopolymers 1996, 39, 297-308.
75. Tuchschere, G.; Scheibler, L.; Dumy, P.; Mutter, M. Protein design: on the threshold of functional properties. Biopolymers 1998, 47, 63-73.
76. Dumy, P.; Eggleston, I. M.; Cervigni, S.; Sila, M.; Sun, X.; Mutter, M. A convenient synthesis of cyclic peptides as regioselectively addressable functionalized templates (RAFT). Tetrahedron Lett. 1995, 36, 1255-1258.
77. Mutter, M.; Tuchscherer, G. Non-native architectures in protein design and mimicry. Cell Mol. Life Sci. 1997, 53, 851-863.
78. Chadiri, M. R.; Soares, C.; Choi, C. A convergent approach to protein design. Metal ion-assisted spontaneous self-assembly of polypeptide into a triplex-helix bundle protein. J. Am. Chem. Soc. 1992, 114, 825-831.
79. Yokokawa, Y.; Grouzmann, E.; Bourgeois, J. P.; Eggleston, I. M.; Dumy, P.; Tuchscherer, G.; Mutter, M. In Peptide proceedings of the European Peptide Symposium; Bajusz, S.; Hudezc, F.; Eds.; Akademiai Kiado: Budapest, 1999; pp322.
80. Sasaki, T.; Kaiser, E. T. Helichrome: synthesis and enzymatic activity of a designed lemeprotein. J. Am. Chem. 1989, 111, 380-381.
81. Akerfeldt, K. S.; Kim, R. M.; Camac, D.; Groves, J. T.; Lear, J.; DeGrado, W. F. Tetraphilin: a four-helix proton channel built on a tetraphenylporphyrin framework. J. Am. Chem. Soc. 1992, 114, 9656-9657.
82. Peluso, S.; Dumy, P.; Eggleston, I. M.; Garouste, P.; Mutter, M. Protein mimetics (TASP) by sequential condensation of peptide loops to an immobilised topological template. Tetrahedron 1997, 53, 7231-7136.
83. Peluso, S.; Nkubana, C.; Dumy, P.; Yokokawa, Y.; Mutter, M. Solid-Phase Strategies for the Assembly of Template-Based Protein Mimetics. J. Org. Chem. 1999, 64, 7114-7120.
84. Mutter, M.; Dumy, P.; Garrouste, P.; Lehmann, C.; Mathieu, M.; Peggion, C.; Peluso, S.; Razaname, A.; Tuchscherer, G. Template assembled synthetic proteins (TASP) as functional mimetics of proteins. Angew. Chem. Int. Ed. Engl. 1996, 35, 1482-1485.
85. Mutter, M.; Tuchscherer, G.; Miller, C.; Altmann, K-H.; Carey, R. I.; Wyss, D. F.; Labhardt, A. M.; Rivier, J. E. Temblate - assembled synthetic proteins with four-helix-bundle topology. Total chemical synthesis and conformational studies. J. Am. Chem. Soc. 1992, 114, 1463-1470.
86. Tuchscherer, G., Dorner, B.; Sila, M.; Kamber, B.; Mutter, M. The TASP concept: mimetics of peptide ligands, protein surfaces and folding unities. Tetrahedron 1993, 49, 3559-3575.
87. Tuchscherer, G.; Mutter, M. Tamplate-Assembled Synthetic Proteins. In Houben-Weyl, Methods of Organic Chemistry. Synthesis of Peptides and Peptidomimetics. Goodman, M.; Felix, A.; Morder, L.; Toniolo, C. Eds.; Thieme: Stuttgart, 2003, E22d:7-67.
88. Tuchscherer, G.; Lehnman, C.; Mathieu, M. New Protein Mimetics: The Zinc Finger Motif as a Locked-In Tertiary Fold. Angew. Chem. Int. Ed. 1999, 37, 2990-2993.
89. Scheibler, L.; Dumy, P.; Boncheva, M.; Leufgen, K.; Mathieu, H. J.; Mutter, M.; Vogel, H. Functional Molecular Thin Films: Topological Templates for the Chemoselective Ligation of Antigenic Peptides to Self-Assembled Monolayers. Angew. Chem. Int. Ed. 1999, 38, 696-699.
90. Callebaut, C.; Jacotot, E.; Krust, B.; Guichard, G.; Blanco, J.; Valenzuela, A., Svab, J.; Muller, S.; Briand, J. P. Pseudopeptide TASP inhibitors of HIV entry bind specifically to a 95-kDa cell surface protein. J. Biol. Chem. 1997, 272, 7159-7166.
91. Sila, M.; Mutter, M. Topological templates as tool in molecular recognition and peptide mimicry: synthesis of a TASK library. J. Mol. Recognit. 1995, 8, 29-34.
92. Tuchscherer, G.; Servis, C.; Corradin, G.; Blum, M.; Rivier, J.; Mutter, M. Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design. Protein Sci, 1992, 1, 1377-1386.
93. Alexopoulos, Ch.; Sakarellos-Daitsiotis, M. ; Sakarellos, C. Synthetic carriers: sequential oligopeptide carriers SOCn-I and SOCn-II as an innovative and multifunctional approach. Curr. Med. Chem. 2005, 12, 1469-1479.
94. Bindra, V.; Kuki, A. Conformational preferences of oligopeptides rich in alpha-aminoisobutyric acid. III. Design, synthesis and hydrogen bonding in 3(10)-helices. Int. J. Pept. Protein Res. 1994, 44, 539-548.
95. Tsikaris, V.; Sakarellos, C.; Cung, M. T.; Marraud, M.; Sakarellos-Daitsiotis, M. Concept and design of a new class of sequential oligopeptide carriers (SOC) for covalent attachment of multiple antigenic peptides. Biopolymers 1996, 38, 291-293.
96. Alexopoulos, Ch.; Tsikaris, V.; Rizou, C.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Cung, M. T.; Marraud, M.; Vlachoyiannopoulos, P. G.; Moutsopoulos, M. The position of the LysN epsilon H2-grafted antigens along the sequential oligopeptide carrier, Ac-(Aib-Lys-Aib-Gly)n (SOCn-II), influences the antibody recognition: application to the Sm main autoimmune epitope. Biopolymers 2000, 54, 1-10.
97. Sakarellos-Daitsiotis, M.; Tsikaris, V.; Vlachoyiannopoulos, P. G.; Tzioufas, A. G.; Moutsopoulos, H. M.; Sakarellos, C. Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptides. Methods 1999, 19, 133-141.
98. Sakarellos-Daitsiotis, M.; Tsikaris, V.; Sakarellos, V. M.; Vlachoyiannopoulos, P. G.; Tziougas, A. G.; Moutsopoulos, H. M. A new helicoid-type sequential oligopeptide carrier (SOC(n)) for developing potent antigens and immunogens. Vaccine 1999, 18, 302-310.
99. Goodman, M.; Felix, A.; Moroder, L.; Toniolo, C.; (eds). Houbeu-Weyl, Methods of Organic Chemistry. Synthesis of Peptides and Peptomimetics. Theme: Stuttgard, 2003; E22a-E22e.
100. Bondansky, M. Principles of Peptide Synthesis, Second ed. Springer: Berlin, 1993.
101. Bodansky, M.; Bodansky, A. The practice of Peptide Synthesis. Second ed. Springer: Berlin, 1994.
102. Stewart, J. M.; Joung, J. D. Principles of Peptide Synthesis. Second ed. Pierce Chemical Co, Rockford IL, 1984.
103. Sakarellos, C.; Tsikaris, V.; Panou-Pomonis, E. ; Alexopoulos, C.; Sakarellos-Daitsiotis, M. ; Petrovas, C. J.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. The PPGMRPP repetitive epitope of Sm autoantigen: antigenic specificity induced by conformational changes. Application of the sequential oligopeptide carriers (SOCs). Lett. Peptide Sci. (LIPS) 1997, 4, 447-454.
104. Alexopoulos, Ch.; Tsikaris, V.; Rizou, C. ; Panou-Pomonis, E.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. A diepitopic sequential oligopeptide carrier (SOCn) as mimic of the Sm autoantigen: synthesis, conformation and biological assays. J. Pept. Sci. 2001, 7, 105-114.
105. Sakarellos-Daitsiotis, M.; Alexopoulos, Ch.; Sakarellos, C. Sequential oligopeptide carriers, SOCn, as scaffolds for the reconstitution of antigenic proteins: applications in solid phase immunoassays. J. Pharm. Biomed. Anal. 2004, 34, 761-769.
106. Tam, J. P.; Health, W. F.; Merrifield, R. B. An SN2 deprotection of synthetic peptides with a low concentration of hydrofluoric acid in dimethyl sulfide: evidence and application in peptide synthesis. J. Am. Chem. Soc. 1983, 105, 6442-6455.
107. Mezö, G.; Oliveira, E.; Krikorian, D.; Feijibrief, M.; Jakab, A.; Tsikaris, V.; Sakarellos, C.; Welling-Wester, S.; Andreu, D.; Hudecz, F. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjug. Chem. 2003, 14, 1260-1269.
108. Tsikaris, V.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Orlewski, P.; Marraud, M.; Cung, M. T.; Vatzaki, E.; Tzartos, S. Construction and application of a new class of sequential oligopeptide carriers (SOCn) for multiple anchoring of antigenic peptides - application to the acetylcholine receptor (AChR) main immunogenic region. Int. J. Biol. Macromol. 1996, 19, 195-205.
109. Wiitrick, K. NMR of Proteins and Nucleic Acids. Wiley: New York, 1986.
110. 1HNMR studies on the preferred interactions of guanidinium and C-terminal carboxylate groups in arginine-containing peptides. J. Chem. Soc. Perkin Trans. 1993, 2, 1345-1349.
111. Wishart, D. S.; Sykes, B. D.; Richards, F. M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 1992, 31, 1647-1651.
112. Tsikaris, V.; Detsikas, E.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Vatzaki, E.; Tzartos, S. J.; Marraud, M.; Cung, M. T. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach. Biopolymers 1993, 33, 1123-1134.
113. Kennedy, D. F.; Crisma, M.; Toniolo, C.; Chapman, D. Studies of peptides forming 3(10)- and alpha-helices and beta-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy. Biochemistry 1991, 30, 6541-6548.
114. Altman, E.; Altman, K. H.; Nebel, K.; Mutter, M. Conformational studies on host-guest peptides containing chiral alpha-methyl-alpha-amino acids. Comparison of the helix-inducing potential of alpha-aminoisobutyric acid, (S)-2-ethylalanine and (S)-2-methylserine. Int. J. Pept. Protein Res. 1988, 32, 344-51.
115. Fasman, G. D. Circular Dichroism and the Conformational Analysis of Biomolecules. Plenum Press, New York, 1996.
116. Chen, Y. H.; Yang, J. T.; Martinez, H. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 1972, 11, 4120-4131.
117. Andrade, M. A.; Chacon, P.; Marelo, J. J.; Moran, F. Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng. 1993, 6, 383-390.
118. Bohm, G.; Muhr, R.; Jaenicke, R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. 1992, 5, 191-195.
119. Wuthrick, K. NMR of proteins and nucleic acids. John Wiley & Sons, Inc., New York, 1986.
120. Wuthrick, K.; Billeter, M.; Braun, W. Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances. J. Mol. Biol. 1984, 180, 715-740.
121. n-II. Functions, Technology-Perspectives. Protein Peptide Lett. 2005, 12, 601-607.
122. Tsikaris, V.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Cung, M. T.; Marraund, M.; Konidou, G.; Tzinia, A; Soteriadou, K. P. Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides. Pept. Res. 1996, 9, 240-247.
123. Tsikaris, V.; Vlachoyiannopoulos, P. G.; Panou-Pomonis, E.; Marraud, M.; Sakarellos, C.; Moutsopoulos, H. M.; Sakarellos-Daitsiotis, M. Immunoreactivity and conformation of the P-P-G-M-R-P-P repetitive epitope of the Sm autoantigen. Int. J. Pept. Protein Res. 1996, 48, 319-327.
124. Petrovas, C. P.; Vlachoyioannopoulos, P. G.; Tzioufas, A. G.; Alexopoulos, Ch.; Tsikaris, V.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Moutsopoulos, H. M. A major Sm epitope anchored to sequential oligopeptide carriers is a suitable antigenic substrate to detect anti-Sm antibodies. J. Immunol. Methods 1998, 220, 59-68.
125. Tzartos, S. J.; Barkas, T.; Cung, M. T.; Mamalaki, M.; Orlewski, P.; Papanastasiou, D.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Tsikaris, V. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 1998, 163, 89-120.
126. Tzartos, S. J.; Loutrari, H.; Tang, F.; Kokla, A.; Walgrave, S. ; Milius, R.; Conti-Troncori, B. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides. J. Neurochem. 1990, 54, 51-61.
127. Papadouli, I.; Potamianos, S.; Hadjidakis, I.; Bairaktari, E.; Tsikaris, V.; Sakarellos, C.; Cung, M. T.; Marraud, M.; Tzartos, S. J. Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor. Biochem. J. 1990, 269, 239-245.
128. Stanford, L.; Peng, J.; Craft, E. Spliceosomal snRNPs autoantibodies. In: Peter, J. B.; Shoenfeld, Y. (Eds), Autuantibodies. Elsevier, 1996, pp. 75.
129. Williams, D. G.; Sharge, N. G.; Wallace, G.; Latchman, D. S. A repeated proline-rich sequence in Sm B/B' and N is a dominant epitope recognized by human and murine autoantibodies. J. Autoimmun. 1990, 3, 715-725.
130. Pruijn, G. J.; Slobbe, R.; Van-Venrooij, W. J. Structure and function of La and Ro RNPs. Mol. Biol. Rep. 1990, 14, 43-48.
131. Gordon, T. P.; Greer, M.; Reynolds, P.; Guidolin, A.; McNeilage, L. J. Estimation of amounts of anti-La(SS-B) antibody directed against immunodominant epitopes of the La(SS-B) autoantigen. Clin. Exp. Immunol. 1991, 85, 402-406.
132. McCluskey, J.; Farris, A. D.; Keech, C. L. Determinant spreading: lessons from animal models and human disease. Immunol. Rev. 1998, 164, 209-229.
133. Tzioufas, A. G.; Yiannaki, E.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Moutsopoulos, H. M. Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization. Clin. Exp. Immunol. 1997, 108, 191-198.
134. Yiannaki, E. E.; Tzioufas, A. G.; Bachmann, M.; Hantoumi, J.; Tsikaris, V.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Moutsopoulos, H. M. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods. Clin. Exp. Immunol. 1998, 112, 152-158.
135. Araga. S.; Xu, L.; Nakashima, K.; Villain, M.; Blalock, J. E. A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help. FASEB J. 2000, 14, 185-196.
136. Routsias, J. G.; Touloupi, E.; Dotsika, E. ; Moulia, A.; Tsikaris, V.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Moutsopoulos, H. M.; Tzioufas, A. G. Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol. Med. 2002, 8, 293-305.
137. Routsias, J. G.; Dotsika, E.; Touloupi, E.; Papamattheou, M.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Moutsopoulos, H. M.; Tzioufas, A. G. Idiotype-anti-indiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J. Autoimmun. 2003, 21, 17-26.
138. Sotiriadou, K. P.; Remoundos, M.S.; Katsikas, M.C.; Tzinia, A.K.; Tsikaris, V.; Sakarellos, C.; Tzartos, S. J. The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin. J. Biol. Chem. 1992, 267, 13980-13985.
139. Tsikaris, V.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Cung, M. T.; Marraud, M., Konidou, G.; Tzinia, A.; Sotiriadou, K. P. Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides. Pept. Res. 1996, 9, 240-247.
140. Vlachoyiannopoulos, P. G.; Petrovas, C.; Tzioufas, A. G.; Alexopoulos, Ch.; Tsikaris, V.; Guialis, A.; Nakopoulou, L.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Davaris, P.; Moutsopoulos, H. M. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs). J. Autommun. 2000, 14, 53-61.
141. Mason, L. J.; Timothy, L. M.; Isenberg, D. A.; Kalsi, J. K. Immunization with a peptide of Sm B/B' results in limited epitope spreading but not autoimmune disease. J. Immunol. 1999, 162, 5099-5105.
142. Tagliabue, A.; Boraschi, D. Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171. Vaccine 1993, 11, 594-595.
143. Boraschi, D.; Tagliabue, A. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants. Methods 1999, 19, 108-113.
144. Ho, P. C.; Mutch, D. A.; Winkel, K. D.; Saul, A. J.; Jones, G. L.; Doran, T. J.; Rzepezyk, C. M.; Identification of two promiscuous T cell epitopes from tetanus toxin. Eur. J. Immunol. 1990, 20, 477-483.
145. Krikorian, D.; Panou-Pomonis, E.; Voitharou, C.; Sakarellos, C.; Sakarellos-Daitsiotis, M. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates. Bioconjug. Chem. 2005, 16, 812-819.
146. Gupta, R. K.; Relyveld, E. H.; Lindblad, E. B.; Bizzini, B.; Ben-Efraim, S.; Gupta, C. K. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 1993, 11, 293-306.
147. Gupta, R. K.; Silber, G. R. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 1995, 13, 1263-1276.
148. Yiannaki, E.; Vlachoyiannopoulos, P. G.; Manousakis, M. N.; Sakarellos, C.; Sakarellos-Daitsiotis, M.; Moutsopoulos, H. M.; Tzioufas, A. G. Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen. Clin. Exp. Immunol. 2000, 121, 551-556.
149. n) of immunogenic peptides with a built-in vaccine adjuvant - Application to reconstituted models of AChR, La/SSB and Sm autoantigens. Peptides 2004, Proceedings of the Third International and Twenty-Eight European Symposium, (Eds. M. Flegel, M. Fridkin, C. Gilon, J. Slaninova), September 5-10, 2004, Prague, Czech Republic, 133-134.